Ars Technica on Nostr: Neuralink says it has the FDA’s OK to start clinical trials Company isn't enrolling ...
Neuralink says it has the FDA’s OK to start clinical trials
Company isn't enrolling patients yet, but has cleared a major hurdle.
https://arstechnica.com/science/2023/05/neuralink-says-it-has-the-fdas-ok-to-start-clinical-trials/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social
Company isn't enrolling patients yet, but has cleared a major hurdle.
https://arstechnica.com/science/2023/05/neuralink-says-it-has-the-fdas-ok-to-start-clinical-trials/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social